AAVE DAO VS. AAVE LABS - TOKEN HOLDERS LOOK TO RECLAIM CONTROL
An AAVE token holder has proposed a radical escalation in Aave governance, using a “poison pill” lawsuit to transfer Aave Labs' IP, trademarks, and even equity to the DAO, effectively turning the for-profit developer into a DAO subsidiary. The move follows backlash over a CoW Swap integration that redirected frontend swap fees from the DAO to a private address, reigniting long-standing tensions over who controls Aave's brand, revenue, and protocol direction.